Search research articles
Contact Us
Filters
Showing results (111-120 of 114) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 114 results.
Melanoma Research
|
December 1, 1992
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma
D F Bajorin, P B Chapman, G Y Wong, et al.
Scientific Reports
|
August 5, 2021
Eristalis flower flies can be mechanical vectors of the common trypanosome bee parasite, Crithidia bombi
Abby E Davis, Kaitlin R Deutsch, Alondra M Torres, et al.
Cancer
|
September 15, 1991
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma
T A Steffens, D F Bajorin, P B Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma
A A Jakubowski, D F Bajorin, M A Templeton, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 114) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 114 results.
Melanoma Research
|
December 1, 1992
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma
D F Bajorin, P B Chapman, G Y Wong, et al.
Scientific Reports
|
August 5, 2021
Eristalis flower flies can be mechanical vectors of the common trypanosome bee parasite, Crithidia bombi
Abby E Davis, Kaitlin R Deutsch, Alondra M Torres, et al.
Cancer
|
September 15, 1991
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma
T A Steffens, D F Bajorin, P B Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma
A A Jakubowski, D F Bajorin, M A Templeton, et al.
Page
of 12